Cantex Pharmaceuticals, Inc. - Sep 14, 2021 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role
10%+ Owner
Signature
/s/ Juan F. Rodriguez, Chief Financial Officer
Stock symbol
CMRX
Transactions as of
Sep 14, 2021
Transactions value $
-$37,375,000
Form type
4
Date filed
9/16/2021, 04:05 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock, par value $0.001 Sale -$37.4M -6.5M -65% $5.75* 3.5M Sep 14, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Cantex Pharmaceuticals, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.